Nikitha Vobugari, MD

University of Minnesota Masonic Cancer Center

Medical oncologist and Assistant Professor in the Division of Hematology, Oncology and Transplantation at the University of Minnesota in Minneapolis.

Published Articles (1)

Triple Negative Breast Cancer in 2026: ADCs Move to the Front, Immunotherapy Stays Central, and Biomarkers Still Lag Behind

June 2, 2026

ADCs are moving to the front line in metastatic TNBC, immunotherapy's role in early-stage disease is being refined, and biomarkers still lag behind. Dr. Nikitha Vobugari breaks down where the field stands in 2026.